The air cleanliness level of the relevant processes and environmental areas of drug production shall comply with the requirements of the current national Drug Production Quality Management Practice and Appendix A.
When there are multiple processes in the medical clean room (area), the corresponding air cleanliness level should be adopted according to the production process requirements.
Under the premise of meeting the requirements of the production process, the air flow pattern of the medical clean room should be a combination of local purification in the work area and the whole room air purification.
The air cleanliness level of various pharmaceutical production processes in the production environment should follow the relevant regulations and refer to Table 1-5.
The standard regulations of suspended particles at all levels of the pharmaceutical industry are shown in Table 1-6.
Table 1-5 Air cleanliness level of pharmaceutical production process production environment (1)
Air cleanliness grade Process drug classification |
Example |
|||||
B+A |
C+A |
B |
C |
D |
||
Sterile drug |
Final sterilizing drug |
|
Large volume injection (≥50ml) |
|
Product filling or potting |
capping |
High contamination risk *2 Preparation and filtration of products |
Preparation of materials before filling |
|||||
High contamination risk*1 Filling or potting of products |
Preparation, filling or potting of ophthalmic preparations, aseptic plasters, aseptic suspensions, etc |
Product preparation and filtration (concentrated or thin in closed systems) |
||||
Disposal of packaging materials and utensils in direct contact with pharmaceuticals after final cleaning |
Final cleaning of packaging materials and utensils in direct contact with pharmaceuticals |
|||||
|
The operation and operation of the product under the condition of incomplete sealing *3, such as product filling or filling, subpacking, stuffing, capping *4, etc |
|
Transshipment of products in a fully sealed container in an incomplete sealed *3 state |
Formulation of a liquid medicine or product that can be sterilized and filtered before filling |
Final cleaning, assembly or packaging, sterilization of packaging materials and utensils that come into direct contact with pharmaceuticals |
|
Preparation of liquid medicine or products that cannot be filtered before filling |
||||||
Non-final sterilizing drug |
Packaging materials in direct contact with pharmaceutical products, assembly of sterilized utensils, and transport and storage under incomplete seal conditions |
|
The transfer and storage of packaging materials and utensils in direct contact with drugs in completely sealed containers after sterilization |
Product filtration |
||
Crushing, sieving, mixing and packaging of sterile apis |
Note:
1. The high risk of contamination here refers to the situation that the product is easy to grow bacteria, the filling speed is slow, the filling container is a wide-mouth bottle, and the window must be exposed for a few seconds before it can be sealed;
2. The high risk of contamination here means that the product is easy to grow bacteria, it takes a long time to sterilize after preparation, or it is not prepared in a closed window;
3. The product shall be deemed to be in an incomplete sealed state before rolling;
4. According to the tightness of the covered product, the design of the rolling equipment, the characteristics of the aluminum cover and other factors, the rolling operation can be selected in the class A air supply environment under the background of class C or D. Class A air supply environment should at least meet the static requirements of class A area.
Table 1-5 Air cleanliness level of pharmaceutical production process production environment (2)
Air cleanliness grade Process drug classification |
Example |
|||||
B+A |
C+A |
B |
C |
D |
||
Non-sterile drug |
|
|
|
|
Exposure procedure for non-final sterilization of oral liquid drugs |
Exposure procedure for final sterilization of oral liquid products |
Exposure procedure for ophthalmic drugs |
Exposure procedure for oral solid drugs |
|||||
Exposure procedure for topical drugs |
||||||
Exposure procedure for endovascular drugs other than rectal drugs |
Exposure procedure for rectal medication |
|||||
Exposure process for the final disposal of packaging materials that come into direct contact with the above drug products |
The exposure process for the final handling of packaging materials and appliances that come into direct contact with the above drug products |
|||||
Bulk drug |
Sterile apis |
Refined, dry, packaged exposure environment |
|
|
|
|
Non-sterile apis |
|
|
|
|
Refined, dry, packaged exposure environment |
|
Biological product |
Products not filtered by sterilization before filling |
Preparation, combination, potting, freeze-drying, plugging, adding stabilizer, adjuvant, inactivator, etc |
|
|
|
|
Products filtered by sterilization before filling |
potting |
|
Preparation, combination, refining, adding stabilizer, adjuvant, inactivation agent, dedrug filtration, ultrafiltration, etc |
|
|
|
|
|
|
|
The combination of raw plasma |
|
|
|
|
|
|
Non-low temperature extraction |
|
|
|
|
|
|
Pasteurize before subpacking |
|
|
|
|
|
|
capping |
|
|
|
|
|
|
Final container cleaning, etc |
|
Table 1-5 Air cleanliness level of pharmaceutical production process production environment (3)
Air cleanliness grade Process drug classification |
Example |
|||||
B+A |
C+A |
B |
C |
D |
||
Biological product |
Oral preparation |
|
|
|
Fermentation, culture closed system |
|
Enzyme-linked immunosorbent reagent |
|
|
|
Packaging, mixing, packaging, drying |
|
|
In vitro immunoreagent |
|
|
|
Production environment |
|
|
Products for deep tissue and large surface wounds |
|
|
|
Preparation and filling |
|
|
Radioactive drug |
Sterile drug |
Requirements related to sterile drugs |
||||
Non-sterile drug |
|
|
|
Requirements related to non-sterile drugs |
||
Sterile apis |
Same as sterile apis |
|||||
Non-sterile apis |
|
|
|
Same as non-sterile apis |
||
Radioimmunoassay box components |
|
|
|
|
preparation |
|
Traditional Chinese medicine |
Non-wound preparation for external use |
|
|
|
|
preparation |
Direct use of pure medicinal materials, dry paste |
potting |
|
|
|
Mix, crush, mix, sift |
|
Sterile drug |
Requirements related to sterile drugs |
|||||
|
|
|
|
|
Requirements for sterile drugs in Central Africa |
Table 1-6 Standard requirements for suspended particles at all levels of the pharmaceutical industry
Rank |
Static |
Dynamic[3] |
||
Maximum allowable number of suspended particles/m³ |
||||
≥0.5um |
≥5.0um[2] |
≥0.5um |
≥5.0um |
|
A[1] |
3520 |
20 |
3520 |
20 |
B |
3520 |
29 |
352000 |
2900 |
C |
352000 |
2900 |
3520000 |
29000 |
D |
3520000 |
29000 |
unspecified |
unspecified |
Note:
1. In order to determine the grade of the eight-level zone, the sampling volume of each sampling point shall not be less than 1m3. The airflow speed is 0.3m/s~0.54m/s.
2. When confirming the level, a short portable dust particle counter should be used; Dynamic sampling heads should be used in unidirectional flow systems.
3. It can be routinely operated and tested during the media simulation filling process to prove that it has reached the dynamic level, but the culture simulation test requires dynamic testing under the "worst condition".
(Training Materials for Clean Room Engineers)